Get to the crux of the matter faster with our unique blend of data, analytics, and expertise. Whether you need a broad market overview or a detailed product or company analysis, Evaluate takes you from exploration to full understanding quickly and accurately.
Our experts will help you identify the tools and insights that support your strategic, commercial, or investment priorities.
Not sure which solutions are right for you? Get in touch with our team, and we’ll talk through your needs.
Learn how Evaluate uses AI to help you make confident decisions faster.
Leveraging a foundation of extensive Evaluate data, augmented with secondary research, modelling and analysis, our pharmaceutical consulting solutions are data-driven and insight-focused. We also conduct targeted primary research with Key Opinion Leaders, healthcare professionals and payers to validate our assumptions and test our hypotheses.
As part of Norstella, our team has access to an unparalleled range of insights, expertise and deep industry knowledge.
Screening and valuing pharma assets is a complex business and making sense of all the data points can be a real challenge. Our solutions provide an accurate, impartial, and timely view of pharma asset potential. Forecast product-level risk, costs, and timelines to make key commercial decisions with confidence.
Check your assumptions, conduct deep due diligence, and assess the value of a potential target or your own portfolio with objectivity. Whether you are looking to expand your product pipelines or enter new markets, find out how our asset screening tools can inform your strategic decision-making.
When bringing new assets into your pipeline, you need a deep understanding of their potential clinical and commercial differentiation and their competitive landscape.
Access the breadth and depth of insights you need to prioritize opportunities and amplify commercial success. We combine company financials and profiles, product attributes, consensus forecasts, and market knowledge to help you take the right products to the right market in the right way.
We combine company financials and profiles, product attributes, consensus forecasts, and market knowledge to help you make the right competitive decisions for your portfolio strategy.
Tracking potential partners and acquisition targets helps you seize opportunities and manage portfolio risk. But company profiling can be complex and time-consuming. As your team sifts through multiple datasets, how do you find timely insights and avoid bias?
Our solutions enable you to find and track the right companies to strengthen your growth strategy. Easily track financials, pipeline developments, M&A activity, and more. Validate potential investments with confidence and strategically prioritize your portfolio for the highest return.
Understanding your competitive landscape is crucial to long-term success. However, it is a colossal task, with a multitude of data points, developments, and decisions for you and your team to track. And it is always evolving.
Our tools put the insights you need within reach, helping you understand risk, identify unmet needs, and better understand your growth drivers and product differentiators. Cut through the layers of complexity and analyze the competition through a lens that’s specific to your therapeutic area or drug class. Discover emerging opportunities and plan the best points of entry for your investment, and stay competitive in the face of market changes.
Are you exploring opportunities for alliances, in-licensing, or acquisition? Use Evaluate’s benchmarking and negotiation tools to understand the dealmaking landscape, with a depth of historical data for context. Easily compare metrics to validate decisions on partnerships, R&D strategies, and deal value. Use detailed data on comparable deals to structure and negotiate from a position of confidence.
Access insights that span therapy areas, mechanisms of action, and technologies. With a comprehensive perspective, you have the edge needed to secure higher deal values and drive R&D success.
When bringing new assets into your pipeline, you need a deep understanding of their potential clinical and commercial differentiation, their competitive landscape, and the overall dynamics of the market they’re in.
Gain invaluable insights into success rates, project timelines, R&D spending, and patient costs. By leveraging our platform, you can conduct thorough assessments of potential within therapy areas, identify unmet needs from patient and market perspectives, and strategically position yourself against your competitors.
Our experts can help you turn this use case into actionable strategy
Get in touch with our team to explore the right solutions for your business.
